---
schema_version: "secwatch.filing_event.v1"
accession: "0001217234-26-000019"
form_type: "8-K/A"
ticker: "CDNA"
cik: "0001217234"
company_name: "CareDx, Inc."
filed_at: "2026-02-25T23:59:59+00:00"
generated_at: "2026-05-16T00:08:43.412537+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# CareDx Q4 rev $108M +25% YoY, FY25 rev $380M; FY26 guide $420-444M; CFO resigns, Kennedy appointed

## Summary
- Q4 revenue $108M (+25% YoY); full-year revenue $380M (+14%). FY2026 guidance $420-444M.
- Q4 GAAP net loss $4M vs $88M income (prior year had $96M litigation reversal); FY25 GAAP loss $21M; adj. EBITDA $32M.
- Testing services Q4 rev $78M (+23%), volume ~53K tests (+17%); full-year rev $275M.
- CFO Nathan Smith resigns for personal reasons; Keith Kennedy (COO since Sept 2024) appointed CFO & COO effective Feb 26.
- Smith separation: 9 months base salary, $91,643 bonus, COBRA reimbursement, and 5,840 RSUs vesting.

## SEC filing metadata
- accession: 0001217234-26-000019
- form_type: 8-K/A
- ticker: CDNA
- cik: 0001217234
- company_name: CareDx, Inc.
- filed_at: 2026-02-25T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01, 5.02, 7.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1217234/000121723426000019/0001217234-26-000019-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1217234/000121723426000019/cdna-20260224.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001217234-26-000019
- JSON: https://secwatch.observer/filing/0001217234-26-000019.json
- Plain text: https://secwatch.observer/filing/0001217234-26-000019.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.